- Home
- A-Z Publications
- Current Drug Delivery
- Previous Issues
- Volume 15, Issue 3, 2018
Current Drug Delivery - Volume 15, Issue 3, 2018
Volume 15, Issue 3, 2018
-
-
Chemotherapy with si-RNA and Anti-Cancer Drugs
Authors: Kamaljeet Kaur, Goutam Rath, Saket Chandra, Ranjit Singh and Amit K. GoyalBackground: To treat cancer, chemotherapy is a key therapeutic approach which is associated with several limitations. This chemotherapeutical agent exhibits multi drug resistance coupled with undesirable side effects. This multidrug resistance is exhibited by tumor cell due to actuation of drug out flow mechanism, programmed cell death and protection mechanisms etc. One of the therapeutic approaches to cure cancer is Read More
-
-
-
Tuberculosis Treated by Multiple Drugs: An Overview
Authors: Gyanendra Singh, Prashant Kesharwani and Anand K. SrivastavaBackground: Tuberculosis is an infection and caused by gentle growing bacteria. The Internet provides opportunities for people with tuberculosis (TB) to connect with one another to address these challenges. Objective: The aim of this paper is to introduce readers to the platforms on which Tuberculosis participants interact, to discuss reasons for and risks associated with TB-related activity, and to review research related to t Read More
-
-
-
Oral Vaccination Through Peyer's Patches: Update on Particle Uptake
Authors: Edna F. Pais Soares and Olga Maria Fernandes BorgesBackground: Oral immunization has numerous advantages over parenteral administrations. In addition to ease administration, more effective pathogen elimination on the mucosa before spreading into the blood circulation, constitutes the main benefit. This is particularly true for pathogens that enter the body through the oral route. On the other hand, it is the most challenging administration route for peptides, proteins and Read More
-
-
-
PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals
Authors: Sajjad Ahmadpour and Seyed J. HosseinimehrBckground: One of the major challenges of biopharmaceuticals having short plasma half-life is that daily high dose injections are needed which can lead to economic burden, patient inconvenience and undesirable side effects. Increasing the hydrodynamic volume beyond the pore size of the glomerular basal membrane is a viable approach to increase the size of small biopharmaceuticals with short half-life in blood circulation. Read More
-
-
-
Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells
Authors: Yetkin Elitez, Meliha Ekinci, Derya Ilem-Ozdemir, Evren Gundogdu and Makbule AsikogluBackground: Alendronate sodium (ALD) is used orally but it is poorly absorbed from the gastrointestinal (GI) tract. For this reason, microemulsion system was chosen to evaluate ALD from the GI tract after oral delivery. Objective: This study was aimed to prepare water-in-oil (w/o) microemulsion formulation of ALD and evaluate the permeability of ALD microemulsion from Caco-2 cell lines with radioactive and nonr Read More
-
-
-
Impact of Surfactants on Skin Penetration of Dexpanthenol
Objective: It was the aim of this study to evaluate the impact of nonionic and ionic surfactants on skin penetration of dexpanthenol. Methods: The relative potency of three surfactants (two nonionic and one ionic) as enhancers in the permeability of a series of compounds was investigated. The influence of the enhancers was also studied. For this purpose, porcine abdominal skin was prepared and mounted on Franz diffusion cell Read More
-
-
-
Copaiba Oil: Chemical Composition and Influence on In-vitro Cutaneous Permeability of Celecoxib
Background: Use of topical or transdermal administration of Celecoxib (Cxb) is an interesting strategy in cutaneous treatments since it reduces or avoids side effects of the oral route. However, Cxb´s high lipophilicity and the stratum corneum (SC) barrier impair cutaneous penetration. Objective: Evaluation of copaiba oil (C.O) as a potential skin penetration enhancer (P.E) for Cxb. Methods: The chemical composition of C Read More
-
-
-
In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics
Background: Polysaccharide based delivery systems have been successfully used to target drugs to colon. In some recent reports, the superiority of concomitant administration of probiotics with such systems has been established. However, the pharmacokinetics of such symbiotic therapy remain unexplored hitherto. Methods: This study deciphers the pharmacokinetic parameters of guar gum based colon targeted spheroids of sulf Read More
-
-
-
Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study
Background: Bupivacaine is the most used local anesthetic in surgical procedures, producing prolonged anesthesia. The major limiting factor for the clinical use of bupivacaine comes from its systemic toxicity. Nanostructured lipid carriers (NLC) are vehicles for sustained drug delivery that are able to minimize the toxicity and to increase the action time of lipophilic drugs. Methods: This work reports a 22 factorial design, which e Read More
-
-
-
Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir
Authors: Smita Bonde, Nisarg Mavani and Chandrakant BondeBackground: The conventional acyclovir topical therapy has a low efficacy, due to the lack of penetration of a sufficient amount of drug to the target site. Objective: The aim of this work was to formulate and optimize organogel containing acyclovir to enhance the penetration and retention time of acyclovir in the basal epidermis, site of Herpes simplex virus infections. Methods: Microemulsion based organogel containing acy Read More
-
-
-
Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment
Authors: Supang Khondee, Chuda Chittasupho, Singkome Tima and Songyot AnuchapreedaBackground: Triple negative breast cancer (TNBC) is an aggressive disease associated with poor prognosis and lack of validated targeted therapy. Thus chemotherapy is a main adjuvant treatment for TNBC patients, but it associates with severe toxicities. For a better treatment outcome, we developed an alternative therapeutic, doxorubicin (DOX)-loaded micelles targeting human mucin1 protein (MUC1) that is less toxic, mor Read More
-
-
-
Molecular Detection of TEM, SHV and CTX-M Genes Among Gram-negative Klebsiella Isolates
Authors: Taqdees Malik, Asma Naim and Asma SaeedIntroduction: In the past few years, the use of antimicrobial drugs against a wide range of pathogens has increased significantly. This extensive use of drugs has increased the resistance rate in microbial community widely. Molecular techniques for the detection of resistance are more reliable as compared to the conventional phenotypic method. Background: The family Enterobacteriaceae is considered to be an important cause Read More
-
-
-
Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers
Authors: Keke Li, Shanshan Gao, Baocheng Tian, Yanan Shi, Qingzhi Lv and Jingtian HanBackground: Ethosomes, a novel type of percutaneous drug delivery carrier with a lipid bilayer structure, penetrate the skin barrier due to their deformability and malleability, and presence of ethanol that fluidizes lipids in the skin. In order to further enhance the delivery of drugs through the skin, penetration enhancers are widely used. Objective: The objective of this work was to develop an optimized formulation of lornoxica Read More
-
-
-
Development and Optimization by Quality by Design Strategies of Frovatriptan Orally Disintegrating Tablets for Migraine Management
Authors: Natascia Mennini, Serena Orlandini, Sandra Furlanetto, Benedetta Pasquini and Paola MuraBackground: Frovatriptan is a potent anti-migraine agent with unfavourable slow onset of action, available on the market as film-coated tablets. Objective: Optimization, by Quality by Designs strategies, of an orally disintegrating tablet (ODT) formulation of frovatriptan aimed to make its oral administration easier and its dissolution faster than the commercial tablets, thus improving its effectiveness in migraine management. M Read More
-
Volumes & issues
-
Volume 22 (2025)
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/cdd
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
s Preface
Authors: Deng-Guang Yu and He Lv
-
- More Less